Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000071

Chief Legal Officer sold 2,799 shares at $33.54 ($93,878)

  • Chief Legal Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Burns James William · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-24 Exercise or conversion : show line 1 in the form 10b5-1 +6,000 31,449 D
2025-06-24 Sale : show line 2 in the form 10b5-1 −2,799 $33.54 $93,878 28,650 D
Open-market sales · 2,799 sh · avg $33.54 · $93,878

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-24 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −6,000 6,000 D
Loading xslF345X05/wk-form4_1750973184.xml…